JDRF and Cam Med have joined forces to develop a bandage-like insulin patch pump for next-generation “artificial pancreas” systems. JDRF has funded Cam Med, a biotech company specialized in microfluidic-based drug delivery. The company will now advance its Evopump, a thin and flexible pump designed for the delivery of one or more medications.
After FDA setback, Bellicum Pharma is all geared up with new R&D leadership, an ex-Genentech executive
Bellicum Pharma is all geared up just a few days after the FDA placed a clinical hold on its lead cell therapy for cancer, Pharma company has recently added new R&D leadership by appointing ex-Genentech executive William Grossman as its chief medical officer. The company is looking forward to improving the R&D process under new supervision.
British biotech ReViral successfully achieved primary and secondary endpoints in early RSV test
Biotechnology Company ReViral has successfully met its primary and secondary endpoints in a small midstage clinical trial for its experimental med against the respiratory syncytial virus (RSV). The phase II a placebo-controlled test of its oral RSV fusion inhibitor RV521, given to adults infected with the virus, significantly reduced viral load, reduced total mucus weight and reduced clinical symptoms, compared to a control treatment with no safety concerns as per the reports.
